share_log

Barclays Downgrades Bright Health Gr to Underweight, Raises Price Target to $8

Barclays Downgrades Bright Health Gr to Underweight, Raises Price Target to $8

巴克萊將Bright Health Gr的評級下調至減持,將目標股價上調至8美元
Benzinga ·  2023/06/15 05:52

Barclays analyst Steve Valiquette downgrades Bright Health Gr (NYSE:BHG) from Overweight to Underweight and raises the price target from $4 to $8.

巴克萊分析師史蒂夫·瓦利奎特將Bright Health Gr(紐約證券交易所代碼:BHG)的評級從增持下調至減持,並將目標股價從4美元上調至8美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論